HomeCompareCTXS vs JNJ

CTXS vs JNJ: Dividend Comparison 2026

CTXS yields 4.46% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $3.5K in total portfolio value· pulled ahead in Year 9
10 years
CTXS
CTXS
● Live price
4.46%
Share price
$103.90
Annual div
$4.63
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$592.93
Full CTXS calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CTXS vs JNJ

📍 JNJ pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTXSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTXS + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CTXS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTXS
Annual income on $10K today (after 15% tax)
$378.78/yr
After 10yr DRIP, annual income (after tax)
$503.99/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, JNJ beats the other by $3,482.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTXS + JNJ for your $10,000?

CTXS: 50%JNJ: 50%
100% JNJ50/50100% CTXS
Portfolio after 10yr
$28.5K
Annual income
$2,641.17/yr
Blended yield
9.26%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CTXS
Analyst Ratings
16
Buy
23
Hold
4
Sell
Consensus: Hold
Price Target
$118.33
+13.9% upside vs current
Range: $80.00 — $145.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTXS buys
0
JNJ buys
0
No recent congressional trades found for CTXS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTXSJNJ
Forward yield4.46%2.13%
Annual dividend / share$4.63$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$26.8K$30.3K
Annual income after 10y$592.93$4,689.40
Total dividends collected$5.2K$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$118.33$228.73

Year-by-year: CTXS vs JNJ ($10,000, DRIP)

YearCTXS PortfolioCTXS Income/yrJNJ PortfolioJNJ Income/yrGap
1$11,146$445.62$10,592$272.30+$554.00CTXS
2$12,390$464.18$11,289$357.73+$1.1KCTXS
3$13,740$482.25$12,123$472.89+$1.6KCTXS
4$15,201$499.79$13,141$629.86+$2.1KCTXS
5$16,782$516.78$14,408$846.81+$2.4KCTXS
6$18,490$533.20$16,021$1,151.60+$2.5KCTXS
7$20,333$549.03$18,122$1,588.22+$2.2KCTXS
8$22,321$564.27$20,930$2,228.20+$1.4KCTXS
9← crossover$24,462$578.90$24,792$3,191.91$330.00JNJ
10$26,767$592.93$30,274$4,689.40$3.5KJNJ

CTXS vs JNJ: Complete Analysis 2026

CTXSStock

Citrix Systems, Inc., an enterprise software company, provides workspace, app delivery and security, and professional services worldwide. The company offers workspace services, including Citrix Workspace; Citrix Virtual Apps and Desktops; Collaborative Work Management; Citrix Content Collaboration, a cloud-based file sharing, digital transaction, and storage solution, which provides enterprise-class data services on various corporate and personal mobile devices; Citrix Analytics for Security that assesses the behavior of Citrix Virtual Apps and Desktops, and Citrix Workspace users and applies actions to protect sensitive corporate information; Citrix Analytics for Performance, which uses machine learning to quantify user experience; Citrix Secure Workspace Access that provides an end-to-end solution to implement Zero Trust principles; and Citrix Secure Internet Access, which provides a solution that protects direct internet access for branch and remote workers using unsanctioned apps. It also provides Citrix ADC that offers application delivery controller, on-premise, in-cloud, and SaaS deployment option solutions. In addition, the company provides customer services, hardware maintenance, consulting, and product training and certification services. The company serves healthcare, financial services, technology, manufacturing, consumer, and government agencies. It markets and licenses its products through resellers, distributors, systems integrators, independent software vendors, original equipment manufacturers, and service providers. The company was formerly known as Citrus Systems, Inc. and changed its name to Citrix Systems, Inc. in March 2009. Citrix Systems, Inc. was incorporated in 1989 and is headquartered in Fort Lauderdale, Florida. As of September 30, 2022, Citrix Systems, Inc. was taken private.

Full CTXS Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CTXS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTXS vs SCHDCTXS vs JEPICTXS vs OCTXS vs KOCTXS vs MAINCTXS vs ABBVCTXS vs MRKCTXS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.